Meningitis resident survival guide: Difference between revisions
Line 149: | Line 149: | ||
{{familytree | | | | | | | | | | | | H01| | | | |H01=Continue therapy}} | {{familytree | | | | | | | | | | | | H01| | | | |H01=Continue therapy}} | ||
{{Family tree/end}} | {{Family tree/end}} | ||
*Adapted from IDSA guidlines. | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+ | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Predisposing factor}} | |||
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Common bacterial pathogen}} | |||
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Antimicrobial therapy}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''1 month''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Streptococcus agalactiae, Escherichia coli, Listeriamonocytogenes, Klebsiellaspecie''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Ampicillin plus cefotaxime or ampicillin plus anaminoglycoside''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''1–23 months''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Streptococcus pneumoniae, Neisseria meningitidis,S. agalactiae, Haemophilus influenzae, E. coli''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Ampicillin plus cefotaxime or ampicillin plus anaminoglycoside''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''2–50 years,150 years''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''N . meningitidis, S. pneumoniae,S. pneumoniae, N. meningitidis, L. monocytogenes,aerobic gram-negative bacill''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | '''Vancomycin plus a third-generation cephalosporin,Vancomycin plus ampicillin plus a third-generationcephalosporina,''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Head traumaBasilar skull fracture''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''S. pneumoniae, H. influenzae,group Ab-hemolyticstreptococci''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Vancomycin plus a third-generation cephalospori''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Penetrating trauma''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Staphylococcus aureus,coagulase-negative staphylo-cocci (especiallyStaphylococcus epidermidis),aer-obic gram-negative bacilli (includingPseudomonasaeruginosa)''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Vancomycin plus cefepime, vancomycin plus ceftazi-dime, or vancomycin plus meropenem''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Postneurosurgery''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Aerobic gram-negative bacilli (includingP. aeruginosa),S . aureus, coagulase-negative staphylococci (es-peciallyS. epidermidis)''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''ancomycin plus cefepime, vancomycin plus ceftazi-dime, or vancomycin plus meropenem''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''CSF shunt''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Coagulase-negative staphylococci (especiallyS. epi-dermidis), S. aureus,aerobic gram-negative bacilli(includingP. aeruginosa), Propionibacterium acnes''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" |'''ancomycin plus cefepime, vancomycin plus ceftazi-dime, or vancomycin plus meropenem''' | |||
|- | |||
|} | |||
==Do's== | ==Do's== |
Revision as of 15:11, 8 December 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Niloofarsadaat Eshaghhosseiny, MD[2]
Overview
Meningitis is characterized by inflammation of the leptomeninges.Meningitis causes are divided to infectious and non-infectious process.Infectious causes are included,bacterial,viral,fungal,protozoal and,treponemal. non-infectious causes, such as systemic illnesses that may involve CNS (e.g. neoplasms or connective tissue diseases, such as sarcoidosis, systemic lupus erythematosus (SLE), and wegener's) or certain drugs (e.g. nonsteroidal antiinflammatory drugs, intravenous immunoglobulin, intrathecal agents, and trimethoprim-sulfamethoxazole).The classic triad of meningitis is headache,neck stiffness and fever.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Bacterial:[1]
- Streptococcus pneumoniae
- Neisseria meningitis
- Hemophilus influenza
- Group B streptococcus
- Listeria monocytogenes
Viral:[2]
Fungal:
- Cryptococcus neoformans
- Aspergillus sp.
- Blastomyces dermatitidis
- Coccidioides immitis
- Candida spp.
- Histoplasma capsulatum
- Sporothrix schencki
Diagnosis
Adapted from IDSA guidline
suspicion for bacterial meningitis | |||||||||||||||||||
yes | |||||||||||||||||||
Immuncompromised,new onset seizure,History of CNS dis,altered consciousness,papilledema,focal neuorologic deficit,delay in performance of diagnostic of LP | |||||||||||||||||||
Yes | No | ||||||||||||||||||
Blood culture stat,CTscan | Blood culture and LP stat | ||||||||||||||||||
Negative CTscan | |||||||||||||||||||
LP | |||||||||||||||||||
- Cerebrospinal Fluid Analysis:
Cerebrospinal fluid level | Normal level | Bacterial meningitis[3] | Viral meningitis (except SARS-CoV-2 meningitis) [3] | SARS-CoV-2 associated meningitis | Fungal meningitis | Tuberculous meningitis[4] | Neoplastic meningitis[5] |
---|---|---|---|---|---|---|---|
Cells/ul | < 5 | >300 | 10-1000 | 10-1000 | 10-500 | 50-500 | >4 |
Cells | Lymphocyte | Leukocyte > Lymphocyte | Lymphocyte > Leukocyte | Lymphocyte > Neutrophil | Lymphocyte > Leukocyte | Lymphocyte > Leukocyte | Lymphocyte > Leukocyte |
Total protein (mg/dl) | 45-60 | Typically 100-500 | Normal or slightly high | Normal or slightly high | High | Typically 100-200 | >50 |
Glucose ratio (CSF/plasma)[6] | > 0.5 | < 0.3 | > 0.6 | > 0.6 | <0.3 | < 0.5 | <0.5 |
Lactate (mmols/l)[7] | < 2.1 | > 2.1 | < 2.1 | NA | >3.2 | > 2.1 | >2.1 |
Others | Intra-cranial pressure (ICP) = 6-12 (cm H2O) | CSF gram stain, CSF culture, CSF bacterial antigen | PCR of HSV-DNA, VZV | RT-PCR for detection of viral RNA i n CSF ( not approved by FDA) | CSF gram stain, CSF india ink | PCR of TB-DNA | CSF tumour markers such as alpha fetoprotein, CEA |
Treatment
Adapted from IDSA guidline
suspicion for bacterial meningitis | |||||||||||||||||||||||||||||||||||||||||
yes | |||||||||||||||||||||||||||||||||||||||||
Immuncompromised,new onset seizure,History of CNS dis,altered consciousness,papilledema,focal neuorologic deficit,delay in performance of diagnostic of LP | |||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||
Blood culture stat | Blood culture and LP stat | ||||||||||||||||||||||||||||||||||||||||
Dexamethasone and empirical antibiotic therapy | Dexamethasone and empirical antibiotic therapy | ||||||||||||||||||||||||||||||||||||||||
Negative CTscan of head | Positive CT scan | Csf findings c/w bacterial meningitis | |||||||||||||||||||||||||||||||||||||||
Perform LP | Continue therapy or consider alternative diagnosis | Yes | |||||||||||||||||||||||||||||||||||||||
Continue therapy | |||||||||||||||||||||||||||||||||||||||||
- Adapted from IDSA guidlines.
Predisposing factor | Common bacterial pathogen | Antimicrobial therapy |
---|---|---|
1 month | Streptococcus agalactiae, Escherichia coli, Listeriamonocytogenes, Klebsiellaspecie | Ampicillin plus cefotaxime or ampicillin plus anaminoglycoside |
1–23 months | Streptococcus pneumoniae, Neisseria meningitidis,S. agalactiae, Haemophilus influenzae, E. coli | Ampicillin plus cefotaxime or ampicillin plus anaminoglycoside |
2–50 years,150 years | N . meningitidis, S. pneumoniae,S. pneumoniae, N. meningitidis, L. monocytogenes,aerobic gram-negative bacill | Vancomycin plus a third-generation cephalosporin,Vancomycin plus ampicillin plus a third-generationcephalosporina, |
Head traumaBasilar skull fracture | S. pneumoniae, H. influenzae,group Ab-hemolyticstreptococci | Vancomycin plus a third-generation cephalospori |
Penetrating trauma | Staphylococcus aureus,coagulase-negative staphylo-cocci (especiallyStaphylococcus epidermidis),aer-obic gram-negative bacilli (includingPseudomonasaeruginosa) | Vancomycin plus cefepime, vancomycin plus ceftazi-dime, or vancomycin plus meropenem |
Postneurosurgery | Aerobic gram-negative bacilli (includingP. aeruginosa),S . aureus, coagulase-negative staphylococci (es-peciallyS. epidermidis) | ancomycin plus cefepime, vancomycin plus ceftazi-dime, or vancomycin plus meropenem |
CSF shunt | Coagulase-negative staphylococci (especiallyS. epi-dermidis), S. aureus,aerobic gram-negative bacilli(includingP. aeruginosa), Propionibacterium acnes | ancomycin plus cefepime, vancomycin plus ceftazi-dime, or vancomycin plus meropenem |
Do's
- Administration of empiric antibiotic to suspicious patients immediately after the performance of lumbar puncture or/and blood cultures sampling.
Don'ts
- Do not delay the delivery of empiric antibiotic for clinical investigation.
References
- ↑ Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS; et al. (1993). "Acute bacterial meningitis in adults. A review of 493 episodes". N Engl J Med. 328 (1): 21–8. doi:10.1056/NEJM199301073280104. PMID 8416268.
- ↑ Chigusa S, Moroi T, Shoji Y (2017). "State-of-the-Art Calculation of the Decay Rate of Electroweak Vacuum in the Standard Model". Phys Rev Lett. 119 (21): 211801. doi:10.1103/PhysRevLett.119.211801. PMID 29219400.
- ↑ 3.0 3.1 Negrini B, Kelleher KJ, Wald ER (2000). "Cerebrospinal fluid findings in aseptic versus bacterial meningitis". Pediatrics. 105 (2): 316–9. PMID 10654948.
- ↑ Caudie C, Tholance Y, Quadrio I, Peysson S (2010). "[Contribution of CSF analysis to diagnosis and follow-up of tuberculous meningitis]". Ann Biol Clin (Paris). 68 (1): 107–11. doi:10.1684/abc.2010.0407. PMID 20146981.
- ↑ Le Rhun E, Taillibert S, Chamberlain MC (2013). "Carcinomatous meningitis: Leptomeningeal metastases in solid tumors". Surg Neurol Int. 4 (Suppl 4): S265–88. doi:10.4103/2152-7806.111304. PMC 3656567. PMID 23717798.
- ↑ Chow E, Troy SB (2014). "The differential diagnosis of hypoglycorrhachia in adult patients". Am J Med Sci. 348 (3): 186–90. doi:10.1097/MAJ.0000000000000217. PMC 4065645. PMID 24326618.
- ↑ Leen WG, Willemsen MA, Wevers RA, Verbeek MM (2012). "Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practice". PLoS One. 7 (8): e42745. doi:10.1371/journal.pone.0042745. PMC 3412827. PMID 22880096.